GlassScriptPhysician profile
Ana C Botero
NPI 1225034457
$21,392.59
in general payments reported to CMS, 2019-2025
25 companies · $4,947 in 2025
The $4,947 reported for 2025 was more than what 95% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,285 · 2020: $4,415 · 2021: $1,525 · 2022: $4,850 · 2023: $1,027 · 2024: $1,343 · 2025: $4,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,421 · Food and Beverage: $2,297 · Grant: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,421.06 |
| Food and Beverage | $2,296.63 |
| Grant | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $12,573.98 | 2019-2022 | |
| Stryker Corporation | $2,921.73 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inari Medical, INC. | $1,647.37 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mentor Worldwide LLC | $1,423.22 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Boston Scientific Corporation | $600.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $343.55 | 2020-2025 | Tagrisso |
| Allergan, INC. | $286.44 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $261.57 | 2024 | |
| Siemens Medical Solutions USA, INC. | $207.84 | 2022-2023 | Varian Ethos Treatment Planning, Halcyon, Truebeam |
| Microtransponder, INC. | $176.67 | 2025 | |
| Amgen INC. | $124.99 | 2021 | |
| Integra Lifesciences Corporation | $121.22 | 2023 | Integra, Integra Dermal Regeneration Template |
| Kci USA, INC. | $116.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $113.79 | 2023-2025 | |
| Seagen INC. | $91.24 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $85.21 | 2022 | |
| Motiva USA, LLC | $65.00 | 2025 | |
| Varian Medical Systems, INC. | $58.68 | 2020 | |
| Chiesi USA, INC. | $45.13 | 2024 | Cleviprex |
| Genzyme Corporation | $32.82 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.09 | 2023 | |
| Cardiva Medical, INC. | $13.97 | 2021 | |
| Merck Sharp & Dohme LLC | $13.44 | 2024 | Lynparza, Keytruda |
| Lilly USA, LLC | $12.78 | 2023 | Verzenio, Retevmo, Jaypirca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Botero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.